قالب وردپرس درنا توس
Home / Health / Michigan Hospital selected as trial site for coronavirus vaccine, and it is looking for volunteers

Michigan Hospital selected as trial site for coronavirus vaccine, and it is looking for volunteers



A possible coronavirus vaccine has been transferred to phase 3 trials, and Michiganders will be able to participate in the study.

Henry Ford’s health care system – one of about 90 health care systems nationwide – and the only hospital system in Michigan – has been selected as a trial site for the Moderna mRNA-1273 (COVE) coronavirus vaccine.

The health system involved volunteers in a randomized, double-blind study of whether two-dose vaccination prevented COVID-1

9 infection in individuals exposed to coronavirus. The latest study aims to attract 30,000 volunteers across the country.

“Henry Ford’s health care system is proud to be involved in the fight against this deadly virus,” the hospital said in a statement. “As one of the largest academic medical centers in the region, with over $ 100 million in annual research funding, Henry Ford is involved in numerous COVID-19 efforts with partners around the world.”

Dr Anthony Foachy, the country’s leading expert on infectious diseases, said he was “cautiously optimistic” and a potential vaccine, according to the Washington Post.

Vaccines are usually made from a weakened or inactive virus. However, the tested mRNA-1273 vaccine was not made from SARS-CoV-2 virus, according to Henry Ford’s health care system.

The test vaccine is made from messenger ribonucleic acid (mRNA), a genetic code that tells cells how to produce protein. Protein is a small part of the virus that is thought to help the body’s immune system make antibodies to fight the virus.

Participation in the study is voluntary. Interested residents can apply to participate in the study here. Participants must be at least 18 years old and may not be pregnant or immune-compromised.

Qualifications include individuals at high risk of COVID-19 infection due to their location, circumstances, age, or current medical condition, as well as adults without a history of COVID-19, and individuals who have not had a previous exposure. study vaccine or treatment with COVID-19.

Those who meet the survey parameters will go through an informed consent process, where they will be able to ask questions about participation before enrolling in the survey.

Healthcare professionals and first responders interested in the study are offered by the hospital system to provide their employee for the first face-to-face meeting when registering with the study coordinators.

Participants will have two injections spaced approximately one month apart. They will then visit the site for enrollment five additional times and talk to the training coordinators about 24 times in two years.

“During this time, participants will be closely monitored by the research team for symptoms of COVID-19 and will check whether they have produced antibodies to protect against coronavirus,” the study said. “If a participant is diagnosed with COVID-19 during his or her study, the team will provide the highest level of care, as the health and safety of each participant is our top priority.”

Trial participants have a 50% chance of receiving the study vaccine or placebo, which will be sterile saline without the active vaccine. According to the hospital system, the test vaccine cannot cause infection or disease.

The potential vaccine is being developed by Modern in collaboration with the National Institutes of Health.

Pharmaceutical giant Pfizer and BioNTech, a small German firm, have also announced a trial of a potential coronavirus vaccine for 30,000 people. The company, which has a manufacturing facility in Kalamazoo County, reached $ 1.95 billion with the U.S. government to supply up to 100 million doses of its vaccine by the end of the year.

Pfizer is expected to begin Phase 2b / 3 soon and will also cover up to 30,000 subjects. The review of regulatory norms may begin in October 2020, according to the White House.

As of Monday, July 27, Michigan reported 78,507 confirmed cases of COVID-19 and 6,154 deaths related to infectious respiratory disease. New daily cases in the state have been rising in recent weeks, although new deaths remain low and the percentage of tests that return positive has averaged less than 4%.

For more information on the Moderna Cove vaccine study, visit the Henry Ford Health System website here.

COVID-19 FORECAST TIPS

In addition to washing their hands regularly and not touching their faces, officials recommend practicing social distancing, suggesting that someone may be carrying the virus.

Health services say you should stay at least 6 feet away from others and work at home if possible.

Use disinfectant wipes or disinfectant spray cleaners on frequently touched surfaces in your home (door handles, faucets, countertops) and carry hand sanitizers with you when you enter places such as shops.

Michigan Governor Gretchen Whitmer has also issued executive orders requiring people to wear face and mouth covers in public enclosed and crowded spaces. See explanation of what this means here.

More information is available at Michigan.gov/Coronavirus and CDC.gov/Coronavirus.

For more information on COVID-19 in Michigan, visit https://www.mlive.com/coronavirus/data/.

More about MLive:

Fewer flights, layoffs and flight reductions among the effects of COVID-19 for mid-Michigan airports

Coronavirus antibody testing is expanding in Kalamazoo, but health officials say it’s “low utility.”

Michigan Senator asks FEMA to help school districts buy masks, cover reopening costs


Source link